Who is sponsoring NCT03513445?

NCT03513445 is sponsored by University of Minnesota.

What condition does NCT03513445 study?

NCT03513445 studies Lumbar Disc Herniation, Degenerative Disc Disease, Spondylolisthesis.

What drugs are being tested in NCT03513445?

Interventions: Morphine, Epinephrine, naropin.

What is the status of NCT03513445?

NCT03513445 is currently WITHDRAWN.

Last reviewed 2022-08-16 · How we verify

Efficacy of Peri-Incisional Multimodal Drug Injection in Reducing Post-Operative Pain Following Lumbar Spine Surgery

NCT03513445 Phase 3 WITHDRAWN

This is a randomized prospective study that will compare the use of narcotics in a control group of non-injected patients with a treatment arm of patients injected intra-operatively with a ropivacaine, morphine, and epinephrine cocktail. The investigators hypothesize that this treatment will reduce narcotic use in patients during their hospital stay, and possibly decrease the length of their stay in the hospital.The investigators also hope their pain will be decreased as displayed by their multi-daily Clinically Aligned Pain Assessment (CAPA) score.

Details

Lead sponsor	University of Minnesota
Phase	Phase 3
Status	WITHDRAWN
Start date	2018-06-01
Completion	2022-09

Conditions

Lumbar Disc Herniation
Degenerative Disc Disease
Spondylolisthesis

Interventions

Morphine
Epinephrine
naropin

Primary outcomes

Post-operative narcotic use — Up to 6 weeks

Countries

United States